NUCLEAR MEDICINE BOARD EXAM 2 LATEST VERSIONS AND STUDY GUIDE (VERSION A AND B) ACTUAL EXAM QUESTIONS AND CORRECT DETAILED ANSWERS

NUCLEAR MEDICINE BOARD EXAM 2 LATEST
VERSIONS AND STUDY GUIDE (VERSION A AND
B) 2024-2025 ACTUAL EXAM QUESTIONS AND
CORRECT DETAILED ANSWERS


Practice questions for this set


Learn


Studied 7 terms


Nice work, you're crushing it



Continue studying in Learn




Terms in this set (63)

,In imaging with 67Ga- remaining the same while blood clearance progresses
citrate, target-to-
background ratio
increases over time
because of gallium
concentration in tissue:
remaining the same while
blood clearance
progresses
decreasing while blood
clearance progresses
remaining the same while
blood clearance
decreases
decreasing while blood
clearance decreases

Following the injection of at six hours
67Ga-citrate, imaging can
begin:
immediately
at one hour
at three hours
at six hours

, A technologist is change the collimator to a high-energy collimator
positioning a patient for a
67Ga-citrate imaging
study and notices that a
LEAP collimator is on the
camera. The
recommended action for
the technologist to take is
to:
continue positioning the
patient; the correct
collimator is in place.
change the collimator to a
GAP collimator
change the collimator to a
medium-energy collimator
change the collimator to a
high-energy collimator

A 67Ga image at 48 hours continue imaging because this is normal
after injection displays
bowel activity; the
technologist should:
be concerned that the
wrong
radiopharmaceutical was
administered
change the collimator to
reduce the scatter activity
from the bowel
continue imaging because
this is normal
check to see if a
radiographic study using
contrast was performed